HOME >> BIOLOGY >> NEWS
Awards honor Alt's three decades of genetic cancer research

Frederick W. Alt, a Howard Hughes Medical Institute investigator at the Children's Hospital Boston Department of Molecular Medicine, has received the Clowes Memorial Award from the American Association for Cancer Research, acknowledging his three decades of seminal discoveries in genomic instability and cancer. The Clowes is the oldest award given by the AACR, and recognizes outstanding recent accomplishments in basic cancer research. The award will be presented at the AACR's 95th Annual Meeting in Orlando, Fla. (March 27-31, 2004). This month Alt, who holds a doctorate in Biological Sciences, also received the prestigious Scientific Leadership Award in Immunology from the Irvington Institute for Immunological Research in New York City.

Alt was the first to elucidate a molecular mechanism for genomic instability (an increased tendency to develop gene mutations) involved in promoting cancer. The human genome is at constant risk for mutations due to environmental insults, errors in gene replication, and other factors that can cause chromosomes to break and bits of DNA to be lost, duplicated, or reshuffled to the wrong chromosomes (translocated). Cells have repair mechanisms that constantly fix this damage, but when the repair process breaks down, the genome becomes unstable and cancers are more likely to develop.

Alt's wide-ranging research has important implications for cancer prevention and has sparked much additional research by other scientists. His work has touched on many aspects of genomic instability and cancer. Several key advancements specifically cited by the AACR are detailed below, followed by a description of Alt's more recent work.

Gene amplification

Alt's early work, as a student with Robert Schimke in the 1970s, led to the discovery of a major form of genomic instability known as gene amplification, or creation of many duplicate copies of a gene, sometimes even numbering in the thousands. Studying how
'"/>

Contact: Susan Craig
susan.craig@childrens.harvard.edu
617-355-6420
Children's Hospital Boston
24-Mar-2004


Page: 1 2 3 4 5

Related biology news :

1. Institute for OneWorld Health nominated for the 2004 World Technology Awards
2. Presidential Recognition Awards presented at the 2004 AIUM Annual Convention
3. Workforce achievements celebrated at NASA Marshall Center Awards ceremony
4. APS announces 2004 Distinguished Lecturer Awards
5. Last call for nominations for 2004 National Academies Communication Awards
6. Mind Science Foundation announces Rare Consciousness Research Awards
7. The DFG announces EURYI Awards for Germany
8. Three Pacific Northwest National Laboratory inventions win R&D 100 Awards
9. Call for entries: Science Journalism Awards
10. Heinz Maier-Leibnitz Awards 2003
11. Six reporters named to receive 2002 AAAS Science Journalism Awards

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/14/2019)... ... September 12, 2019 , ... ... solutions for drugs, biologics, gene therapies, and consumer health products, today announced that ... biologics business. Dr. Schaffer has played an integral advisory role on the gene ...
(Date:9/8/2019)... Calif. (PRWEB) , ... September 06, 2019 , ... ... Board of Directors of Nanosens Innovations have each authorized the respective companies to ... a subsidiary of Cardea, with the Nanosens brand representing a series of products ...
(Date:8/27/2019)... ... ... Shoreline Biome , a microbiome research company that develops tools for characterizing ... and Karen Woodward as its VP of Business Development. , These two new ... expand the company’s sales worldwide. , Prior to joining Shoreline Biome, Bill McKenzie was ...
Breaking Biology News(10 mins):
(Date:9/17/2019)... ... September 17, 2019 , ... Tucker, a Labrador retriever, was just a puppy ... was limping and lame on his right hip and elbow. At one year of ... “the worst case the vet had seen.” He was prescribed pain medications, both oral ...
(Date:9/17/2019)... ... September 16, 2019 , ... MyBioGate Global ... Focus @ Biotech Week Boston, a forum organized by MyBioGate, Inc. and CUBIO ... , After a careful process of evaluation, twelve companies out of over 200 ...
(Date:9/9/2019)... ... September 09, 2019 , ... Visikol CEO Dr. Michael Johnson ... focused on how best to characterize 3D cell culture models. The inherent problem of ... too thick and opaque to image through and therefore traditional wide-field or even confocal ...
(Date:8/29/2019)... ... August 29, 2019 , ... ... affecting grapevines, a feat they hope will ultimately help protect the multibillion-dollar grape ... several Rochester Institute of Technology faculty and alumni sequenced the microbiome found within ...
Breaking Biology Technology:
Cached News: